PLCG2 and Alzheimer disease: While several variants in TREM2 associated with loss of function were found to increase AD risk2,36,37, a mutation in PLCγ2 with a hypermorphic effect on enzymatic activity has been shown to be protective18,19, indicating that boosting TREM2 and/or PLCγ2 function could be beneficial in AD.